Studies so time-intensive that they have thus far been impractical may soon enter the mainstream as a result of enhancements to GE Healthcare’s Excite data pipeline.
Studies so time-intensive that they have thus far been impractical may soon enter the mainstream as a result of enhancements to GE Healthcare's Excite data pipeline.
HD (high-definition) MR, the latest version of this technology, is being showcased at the ECR. It promises to have an immediate impact on difficult applications such as brain scans of children and patients with Parkinson's disease. HDMR has a similarly positive effect on motion-sensitive studies of the heart and abdomen, and it speeds up MR mammography by allowing data acquisition from both breasts simultaneously. It even supports dynamic MR angiography of the legs.
"We have designed a system that brings new clinical relevance to the medical community and, in the end, to the patients," said Stefano Vagliani, GE's general manger for MR in Europe. "We created new electronic devices, new interfaces, and clinical software that really brings additional value."
New high-performance surface coils acquire the data that HDMR processes. An example is a 32-element peripheral vascular coil that extends below the knee and covers each foot with what looks like a ski boot. The new coil, in combination with HDMR, allows dynamic imaging of blood flow.
The increased data flow from this and other such coils, along with the advanced processing capabilities of HDMR, enable the capture of MR data in novel ways. One method, called Propeller, acquires data radially rather than in the conventional rectilinear fashion. Propeller is relatively insensitive to motion and is therefore ideally suited for patients prone to movement. LAVA (liver acquisitions with volume acceleration) cuts scan time for liver and other abdominal applications. An acquisition process that mimics echocardiography allows cardiac imaging without ECGs. Other such methods are in the works.
Current Insights and Emerging Roles for Contrast-Enhanced Mammography
May 10th 2024In a recent lecture at the 2024 ARRS Annual Meeting, Jordana Phillips, MD, discussed the role of contrast-enhanced mammography in staging breast cancer, evaluating response to neoadjuvant chemotherapy and recalls from screening.
MRI-Based Deep Learning Algorithm Shows Comparable Detection of csPCa to Radiologists
May 8th 2024In a study involving over 1,000 visible prostate lesions on biparametric MRI, a deep learning algorithm detected 96 percent of clinically significant prostate cancer (csPCa) in comparison to a 98 percent detection rate for an expert genitourinary radiologist.
Breast MRI and Dense Breasts: A Closer Look at Early Findings from a New Prospective Trial
May 2nd 2024Supplemental breast MRI had a cancer detection rate (CDR) of 20/1000 and a positive predictive value (PPV) of 50 percent, according to preliminary findings from a prospective trial involving women with heterogeneously or very dense breasts.